The Uzbek authorities have suspended the sale of all drugs manufactured by the Indian firm Marion Biotech. Among them are Cinepar, Nolgripp, Travamax and others, the spokeswoman to the Agency for the Development of the Pharmaceutical Industry Kizlarkhon Begmatova.
According to her, from December 30, Uzbekistan has suspended the sale of all drugs manufactured by the Indian company Marion Biotech and registered in the country.
Due to the fact that toxic substances were found in the DOK-1 MAX syrup, other medication of this company will be subjected to laboratory tests. Their sale on the territory of Uzbekistan is temporarily suspended.
